Protalix BioTherapeutics (PLX) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 666.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 666.48% |
| Dec 31, 2025 | -131.58% |
| Sep 30, 2025 | -41.74% |
| Jun 30, 2025 | 129.09% |
| Mar 31, 2025 | 21.15% |
| Dec 31, 2024 | 153.80% |
| Sep 30, 2024 | 323.56% |
| Jun 30, 2024 | -111.56% |
| Mar 31, 2024 | -61.21% |
| Dec 31, 2023 | -587.01% |
| Sep 30, 2023 | 51.81% |
| Jun 30, 2023 | 468.34% |
| Mar 31, 2023 | -28.43% |
| Dec 31, 2022 | 51.47% |
| Sep 30, 2022 | 16.95% |
| Jun 30, 2022 | 53.08% |
| Mar 31, 2022 | 61.00% |
| Dec 31, 2021 | -2,179.87% |
| Sep 30, 2021 | 5.71% |
| Jun 30, 2021 | -171.47% |
| Mar 31, 2021 | -500.34% |
| Dec 31, 2020 | 186.49% |
| Sep 30, 2020 | -26.74% |
| Jun 30, 2020 | 45.93% |
| Mar 31, 2020 | 119.64% |
| Dec 31, 2019 | 102.01% |
| Sep 30, 2019 | 35.27% |
| Jun 30, 2019 | 9.27% |
| Mar 31, 2019 | -1.13% |
| Dec 31, 2018 | 47.29% |
| Sep 30, 2018 | 51.49% |
| Jun 30, 2018 | 38.36% |
| Mar 31, 2018 | 12.79% |
| Dec 31, 2017 | -2.95% |
| Sep 30, 2017 | -51.43% |
| Jun 30, 2017 | -27.86% |
| Mar 31, 2017 | 3.60% |
| Dec 31, 2016 | -18.16% |
| Sep 30, 2016 | -25.30% |
| Jun 30, 2016 | -73.98% |
| Mar 31, 2016 | -34.05% |
| Mar 31, 2015 | 11.40% |
| Mar 31, 2014 | -66.17% |
| Dec 31, 2013 | -68.14% |
| Sep 30, 2013 | -1.53% |
| Jun 30, 2013 | -171.66% |
| Mar 31, 2013 | 26.74% |
| Dec 31, 2012 | -14.78% |
| Sep 30, 2012 | 36.58% |
| Jun 30, 2012 | 169.37% |
| Mar 31, 2012 | -20.39% |
| Dec 31, 2011 | -0.11% |
| Sep 30, 2011 | -207.83% |
| Jun 30, 2011 | -36.63% |